Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03519256
Title A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder (CheckMate 9UT)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

bladder urothelial carcinoma

urinary bladder cancer

Therapies

BMS-986205 + Nivolumab

Nivolumab

BCG solution + Nivolumab

BCG solution + BMS-986205 + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.